The Medicines Company (MDCO) was a big mover last session with its shares rising over 10% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $28.34 to $30.34.
This provider of medical solutions for patients in acute and intensive care hospitals has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn’t been in trend either. Thursday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
The Medicines Company currently has a Zacks Rank #3 (Hold) and its Earnings ESP is negative.
A better-ranked Med-BioMed/Gene stock is China Biologic Products, Inc. (CBPO) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment